Articles Vol. 67 No. 8 28/08/2026

ADHERENCE TO ANTIVIRAL THERAPHY AND RELATED FACTORS AMONG PATIENTS WITH HEPATITIS B AT THANH SON REGIONAL MEDICAL CENTER, PHU THO PROVINCE IN 2025

Luong Thi Hai Yen1,2
1 Hai Duong Medical Technical University
2 Trường Đại học Kỹ thuật Y tế Hải Dương
DOI: 10.52163/yhc.v67i8.6302
15 Views
0 Downloads
Keywords
Medication adherence, hepatitis B, antiviral medication.
Abstract

Objective: To determine the medication adherence and related factors in patients with hepatitis B virus infection at Thanh Son regional Medical Center, Phu Tho province in 2025.

Subjects and methods: A cross-sectional study. The research subject is hepatitis B patients who had been using antiviral medication for 3 months or more at Thanh Son regional Medical Center.

Results: In the study of 162 subjects, most patients were low medication adherence, about 59.3%. Analysis showed that the medication adherence was related to factors such as age (p < 0.001), occupation (p = 0.024), and income (p < 0.001). Futhernore, having family members with hepatitis B was associated with a 2.465-fold increase in medication adherence (p = 0.04), while a treatment duration of ≥ 6 years was associated with a 12.491-fold increase (p < 0.001).

Conclusion: The level of medication adherence in hepatitis B patients was low. Demographics factors, as well as family history and duration of treatment, significantly influence the medication adherence. This suggest the need for appropriate interventions to enhanve medication adherence outcomes in this patient group.

References
[1]
World Health Organization. Hepatitis B, Geneva, 2022. https://www.who.int/news-room/fact-sheets/detail/hepatitis-b Google Scholar
[2]
Nguyen V.T.T, Law M.G, Dore G.J. An enormous hepatitis B virus-related liver disease burden projected in Vietnam by 2025. Liver Int, 2008, 28 (4): 525-531. doi: 10.1111/j.1478-3231.2007.01646.x Google Scholar
[3]
Allard N.L, MacLachlan J.H, Dev A et al. Adherence in chronic hepatitis B: associations between medication possession ratio and adverse viral outcomes. BMC Gastroenterol, 2020, 20 (1): 140. doi: 10.1186/s12876-020-01219-w Google Scholar
[4]
Ford N, Scourse R, Lemoine M et al. Adherence to nucleos(t)ide analogue therapies for chronic hepatitis B infection: a systematic review and meta-analysis. Hepatol Commun, 2018, 2 (10): 1160-1167. doi: 10.1002/hep4.1247 Google Scholar
[5]
Seto W.K, Lo Y.R, Pawlotsky J.M et al. Chronic hepatitis B virus infection. Lancet, 2018, 392 (10161): 2313-2324. doi: 10.1016/S0140-6736(18)31865-8 Google Scholar
[6]
Ghany M.G, Pan C.Q, Lok A.S et al. AASLD/IDSA practice guideline on treatment of chronic hepatitis B. Hepatology, 2026, 83 (4): 974-997. doi: 10.1097/HEP.0000000000001549 Google Scholar
[7]
Đỗ Thị Kim Liên, Nguyễn Thị Lan Anh. Tuân thủ điều trị thuốc kháng virus của người bệnh viêm gan virus B mạn tính tại Bệnh viện Đa khoa Quốc tế Hải Phòng năm 2022. Tạp chí Nghiên cứu Y học, 2023, 163 (2): 154-163. doi: 10.52852/tcncyh.v163i2.1404 Google Scholar
[8]
Sawalmeh A, Johansson E.W, Kostas D et al. Hepatitis B patients’ adherence to treatment in relation to knowledge, attitudes, and practices (KAP) in the West Bank, Palestine, 2022-2023. J Viral Hepat, 2025, 32 (1): e14055. doi: 10.1111/jvh.14055 Google Scholar
[9]
Quế Anh Trâm, Nguyễn Thị Diệu Linh, Trần Anh Đào. Đánh giá tuân thủ điều trị thuốc kháng virus và một số yếu tố liên quan của bệnh nhân viêm gan B mạn tính tại Bệnh viện Hữu nghị Đa khoa Nghệ An. Tạp chí Y học Cộng đồng, 2025, 66 (3): 202-206. doi: 10.52163/yhc.v66iCĐ3.2158 Google Scholar
[10]
Nguyễn Thị Hoài Thương, Lưu Thùy Linh, Nguyễn Mạnh Trường. Đánh giá sự tuân thủ điều trị của người bệnh viêm gan virus B mạn tính tại phòng khám viêm gan, Bệnh viện Đa khoa Đức Giang. Tạp chí Truyền nhiễm Việt Nam, 2023, (53): 95-101. doi: 10.59873/vjid.v3i43.314 Google Scholar